High Blood Pressure (Hypertension) Completed Phase 3 Trials for Hydrochlorothiazide (DB00999)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

DBCOND0040789 (High Blood Pressure (Hypertension))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00649389Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionTreatment
NCT00146341Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgTreatment
NCT00311740A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)Treatment
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT00000525Diuretics, Hypertension, and Arrhythmias Clinical Trial
NCT00092209Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)Treatment
NCT00095394Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionTreatment
NCT00095550Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionTreatment
NCT00257491Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionTreatment
NCT00263003Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionTreatment
NCT00327145A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on MonotherapyTreatment
NCT003275878-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionTreatment
NCT00338936Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)Treatment
NCT00355589Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionTreatment
NCT00368277A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the ElderlyTreatment
NCT00383929Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgTreatment
NCT00387517Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With HypertensionTreatment
NCT00386607A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.Treatment
NCT00386139A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive PatientsTreatment
NCT00398541Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)Treatment
NCT00402103An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood PressureTreatment
NCT00434967Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboTreatment
NCT00459056The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive PatientsTreatment
NCT00523744Efficacy and Safety of Valsartan and Amlodipine (┬▒ HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionTreatment
NCT00548067Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionTreatment
NCT00546052A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)Treatment
NCT00670787Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance TrialTreatment
NCT00765674Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe HypertensionTreatment
NCT00797862Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for HypertensionDiagnostic
NCT00886600A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)Treatment
NCT01365481Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeTreatment
NCT01415505Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionTreatment
NCT01911780Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineTreatment
NCT01975246Add-on to Micamlo BP TrialTreatment
NCT02183701Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential HypertensionTreatment
NCT02177487Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionTreatment
NCT02177500Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyTreatment
NCT02177435Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionTreatment
NCT02177422Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionTreatment
NCT02175355Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)Treatment
NCT00642096Factorial Study of Metoprolol Succinate TOPROL-XL (324A)Treatment